Moleculin Biotech Inc reports results for the quarter ended in June - Earnings Summary

Moleculin Biotech

11/08/2023 14:31

* Moleculin Biotech Inc  MBRX.OQ  reported a quarterly
adjusted
loss of 20 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 27 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Moleculin Biotech Inc's reported EPS for the quarter was a
loss
of 20 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Moleculin Biotech Inc shares had risen by 8.8% this
quarter and
lost 40.6% so far this year.
    * The company reported a quarterly loss of $5.98 million.
    * Wall Street's median 12-month price target for Moleculin
Biotech
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 11 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.27          -0.20          Beat
 Mar. 31 2023      -0.25          -0.28          Missed
 Dec. 31 2022      -0.30          -0.23          Beat
 Sep. 30 2022      -0.27          -0.30          Missed